Portage Biotech Inc (PRTG) has released an update.
Portage Biotech Inc. has released its financial statements for the three months ending June 30, 2024, showing a calculated management of assets and liabilities. The unaudited report, prepared under International Financial Reporting Standards, indicates a reduction in total assets and shareholders’ equity compared to the previous quarter. The company’s expenses, including research and development as well as general and administrative expenses, have led to a loss from operations, despite a positive change in the fair value of warrant liability.
For further insights into PRTG stock, check out TipRanks’ Stock Analysis page.
